Stocks · Health care · Pharmaceutical Preparations

Perspective Therapeutics, Inc.

CATX Clue Score36
United States Fiscal year ends December CIK 0000728387 Results filed 10 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Lantheus Alpha Therapy, LLC
4 Sep 2026
10% owner
Sell
167,149
$3.15
$526.05K
Lantheus Alpha Therapy, LLC
3 Sep 2026
10% owner
Sell
80,783
$3.11
$250.90K
Lantheus Alpha Therapy, LLC
2 Sep 2026
10% owner
Sell
42,129
$3.11
$131.22K
Lantheus Holdings, Inc.
1 Sep 2026
10% owner
Sell
35,769
$3.12
$111.57K
Lantheus Alpha Therapy, LLC
1 Sep 2026
10% owner
Sell
35,769
$3.12
$111.57K
Lantheus Holdings, Inc.
31 Aug 2026
10% owner
Sell
78,145
$3.14
$245.61K
Lantheus Alpha Therapy, LLC
31 Aug 2026
10% owner
Sell
78,145
$3.14
$245.61K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 7
Transactions with no price 0
Shares from compensation/vesting 0
History held since 26 Oct 2006